Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elastin stabilizes an infarct and preserves ventricular function.

Tomohiro Mizuno1, Terrence M Yau, Richard D Weisel

  • 1Toronto General Research Institute, Division of Cardiovascular Surgery, Department of Surgery, Toronto General Hospital, University of Toronto, Canada.

Circulation
|September 15, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 3D-printed extravascular stent containing sirtuin-3 engineered human bone marrow mesenchymal stem cells maintains venous graft patency.

Stem cell research & therapy·2026
Same author

CASPR2 antibody-related neurological syndromes in children: three cases report and literature review.

BMC pediatrics·2026
Same author

B cells drive CD4 T cell immunosenescence and age-associated health decline.

Science immunology·2026
Same author

Impaired autophagy flux contributes to enhanced ischemia reperfusion injury in the diabetic heart.

Autophagy reports·2025
Same author

A Novel Protein NAB1-356 Encoded by circRNA circNAB1 Mitigates Atrial Fibrillation by Reducing Inflammation and Fibrosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

A conductive polymer restores connexin43 expression through the suppression of mitogen-activated protein kinases to improve intercellular communication and alleviate atrial fibrillation.

Acta biomaterialia·2025
Same journal

A Bundle to Frame Guidelines and American Heart Association Statements.

Circulation·2026
Same journal

<i>Circulation</i> Editors and Editorial Board.

Circulation·2026
Same journal

A New <i>Circulation</i>, For You.

Circulation·2026
Same journal

Cardiovascular Risk Reduction With GLP-1 RA Drugs.

Circulation·2026
Same journal

Obesity, Severe Obesity, and Abdominal Obesity in US Youth and Adults From 1999 to 2023.

Circulation·2026
Same journal

Lipid Profile Testing and Interpretation.

Circulation·2026
See all related articles

Gene therapy delivering elastin to myocardial scars improved heart function and reduced scar expansion after heart attack. This approach preserved left ventricular (LV) function by altering matrix remodeling, offering a promising strategy for heart failure treatment.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Biomaterials Science

Background:

  • Myocardial infarction leads to fibrotic scarring, potentially causing ventricular wall expansion and progressive heart failure due to reduced elasticity.
  • Cardiac dilatation following infarction can initiate a detrimental cycle of worsening heart failure.
  • Current treatments aim to manage heart failure progression after myocardial infarction.

Purpose of the Study:

  • To evaluate the functional benefits of enhancing elastin content within myocardial scars using cell-based gene therapy.
  • To determine if increased elastin can mitigate adverse cardiac remodeling post-myocardial infarction.
  • To assess the long-term impact of scar modification on cardiac function.

Main Methods:

  • Myocardial infarction was induced in rats via left anterior descending artery ligation.

Related Experiment Videos

  • Syngeneic rat endothelial cells genetically modified to express elastin were transplanted into the infarct scar.
  • Cardiac function, left ventricular volume, and infarct size were monitored for 3 months using echocardiography, Langendorff measurements, and planimetry.

    • Main Results:

    • Recombinant elastin was successfully detected in the infarct scar for 3 months post-transplantation in the elastin group.
    • Histological analysis revealed organized elastic fibers within the scar tissue of the elastin group.
    • The elastin group exhibited significantly smaller left ventricular volumes and infarct sizes compared to controls (P<0.05).
    • Cardiac function was significantly improved in the elastin group, as assessed by echocardiography and Langendorff perfusion (P<0.05).

    Conclusions:

    • Recombinant elastin expression within myocardial scars effectively reduced scar expansion and prevented left ventricular enlargement after myocardial infarction.
    • Modifying matrix remodeling in the infarct zone preserved left ventricular function for at least 3 months.
    • Cell-based gene therapy targeting scar elasticity presents a viable strategy for improving outcomes after myocardial infarction.